Top Stories

Decisio Health is Recognized as a Finalist for the Fierce Innovation Awards

UT Horizon Fund portfolio company, Decisio Health, is recognized as a finalist for the Fierce Innovation Awards: Healthcare Edition.

Apollo Endosurgery Aims to Expand Definition of Digestive Treatments

Apollo Endosurgery, a UT Horizon Fund Portfolio Company,  aims to expand definition of digestive treatments.

MicroTransponder developing neurostimulation technology for tinnitus and stroke victims

UT Horizon Fund Portfolio Company, MicroTransponder, developing neurostimulation technology to allow tinnitus and stroke victims to re-train their brains.

Aeglea BioTherapeutics Announces IND Application Approval

Aeglea BioTherapeutics, UT Horizon Fund Portfolio Company, announces IND application approval.

UT Horizon Fund portfolio company Lung Therapeutics named 1 of Biotech Showcase’s Most Interesting Startup